Catalog No.
RVV13201
Species reactivity
Monkeypox virus(MPXV)
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Target
E8L, Cell surface-binding protein, Carbonic anhydrase homolog
Concentration
2.71 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
NP_536532.1
Applications
ELISA, Neutralization, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA0285
Rational development of multicomponent mRNA vaccine candidates against mpox. [RVV13201]
Multi-Component Protein Vaccine Induces a Strong and Long-Term Immune Response Against Monkeypox Virus. [RVV13201]
Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic development., PMID:39994775
A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates., PMID:39639037
Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART II: Insights into the advancements in vaccines., PMID:39417768
Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus., PMID:39321566
Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory., PMID:39247273
Discordant performance of mpox serological assays., PMID:39127186
Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens., PMID:38829493
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study., PMID:37475115
Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity., PMID:37300753
In silico designing a novel TLR4-mediating multiepitope vaccine against monkeypox via advanced immunoinformatics and bioinformatics approaches., PMID:37129119
Rational development of multicomponent mRNA vaccine candidates against mpox., PMID:36947428
A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L., PMID:36423140
For research use only. Not for human or drug use.
